3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Colorectal Neoplasms
8
Venous Thromboembolism
4
Polycythemia Vera
3
Prostatic Neoplasms
2
Neoplasms
2
Myeloproliferative Disorders
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Breast Neoplasms
2
Thrombocythemia, Essential
1
Testicular Neoplasms
1
Smoking Cessation
1
Sarcoma
1
Primary Myelofibrosis
1
Ovarian Neoplasms
1
Ovarian Cancer Prevention
1
Neuroma, Acoustic
1
Neurofibromatosis 2
1
Neoplasms, Germ Cell and Embryonal
1
Multiple Myeloma
1
Motor Activity
1
Lung Neoplasms
1
Liver Cirrhosis
1
Leukemia, Hairy Cell
1
Inflammation
1
Hemorrhage
1
Hematoma
1
Fibrosis
1
Endometrial Neoplasms
1
Colorectal Neoplasia
1
Interventions
Magnetic Resonance Spectroscopy
3
Blood Specimen Collection
3
Specimen Handling
2
Simvastatin
2
Liver Transplantation
2
tremelimumab
1
sofosbuvir-velpatasvir drug combination
1
epigallocatechin gallate
1
durvalumab
1
atezolizumab
1
apixaban
1
User-Centered Design
1
Tocopherols
1
Surveys and Questionnaires
1
Standard of Care
1
Sodium Chloride
1
Sampling Studies
1
Radiotherapy
1
Radiation
1
Pravastatin
1
Phlebotomy
1
Pharmaceutical Preparations
1
Pentoxifylline
1
Patient Navigation
1
Neuropsychological Tests
1
Musculoskeletal Manipulations
1
Memantine
1
Losartan
1
Ketoprofen
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fibrosis
×
Aspirin
×
1 year
×
Clear all
NCT07529262
2026-04-14
AspiRe HCC
Curtin University
Phase 3
Not yet recruiting
890 enrolled